Construction and prognostic value of enhanced CT image omics model for noninvasive prediction of HRG in bladder cancer based on logistic regression and support vector machine algorithm
暂无分享,去创建一个
[1] Liangren Liu,et al. The Prognostic and Clinicopathological Significance of Systemic Immune-Inflammation Index in Bladder Cancer , 2022, Frontiers in Immunology.
[2] M. Fabritius,et al. Accuracy and prognostic value of radiological lymph node features in variant histologies of bladder cancer , 2022, World Journal of Urology.
[3] Minhong Wu,et al. Prognostic Role of Pretreatment C-Reactive Protein to Albumin Ratio in Urological Cancers: A Systematic Review and Meta-Analysis , 2022, Frontiers in Oncology.
[4] M. Ge,et al. Radiomics signature for the prediction of progression-free survival and radiotherapeutic benefits in pediatric medulloblastoma , 2022, Child's Nervous System.
[5] Huijie Jiang,et al. A Potential Prognostic Marker for Recognizing VEGF-Positive Hepatocellular Carcinoma Based on Magnetic Resonance Radiomics Signature , 2022, Frontiers in Oncology.
[6] Ş.M. Ertürk,et al. Classification of retinoblastoma-1 gene mutation with machine learning-based models in bladder cancer , 2022, Heliyon.
[7] Y. Lotan,et al. Prognostic Role of Preoperative Vascular Cell Adhesion Molecule-1 Plasma Levels in Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy , 2022, Annals of Surgical Oncology.
[8] Yan Zhao,et al. Computed Tomography Radiomics-Based Prediction of Microvascular Invasion in Hepatocellular Carcinoma , 2022, Frontiers in Medicine.
[9] X. Liu,et al. CT-based radiomics for the preoperative prediction of the muscle-invasive status of bladder cancer and comparison to radiologists' assessment. , 2022, Clinical radiology.
[10] M. Ladanyi,et al. Zenocutuzumab, a HER2xHER3 Bispecific Antibody, Is Effective Therapy for Tumors Driven by NRG1 Gene Rearrangements , 2022, Cancer discovery.
[11] K. Bar,et al. Neutrophil-to-lymphocyte ratio as a predictor of overall survival and cancer advancement in patients undergoing radical cystectomy for bladder cancer , 2022, Central European journal of urology.
[12] Tianyuan Xu,et al. Magnetic resonance imaging-based radiomics signature for preoperative prediction of Ki67 expression in bladder cancer , 2021, Cancer Imaging.
[13] Zhi-gang Yang,et al. Radiomic assessment as a method for predicting tumor mutation burden (TMB) of bladder cancer patients: a feasibility study , 2021, BMC cancer.
[14] B. Hadaschik,et al. The prognostic value of cytokeratin and extracellular collagen expression in urinary bladder cancer. , 2021, Current molecular medicine.
[15] Hong Yang,et al. Radiomics Analysis Based on Ultrasound Images to Distinguish the Tumor Stage and Pathological Grade of Bladder Cancer , 2021, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.
[16] Lifang Wang,et al. Targeting neuregulin 1 (NRG1): A novel biomarker for non-small-cell lung cancer , 2021, Journal of Environmental Pathology And Toxicology.
[17] A. Lenis,et al. Bladder Cancer: A Review. , 2020, JAMA.
[18] Yuichi Sato,et al. PD-L1 expression in tumor-infiltrating lymphocytes (TILs) as an independent predictor of prognosis in patients with pN0 bladder cancer undergoing radical cystectomy. , 2020, Urologic oncology.
[19] C. Catalano,et al. VI‐RADS for Bladder Cancer: Current Applications and Future Developments , 2020, Journal of magnetic resonance imaging : JMRI.
[20] Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. , 2020, CA: a cancer journal for clinicians.
[21] Q. Wei,et al. Prognostic values of the clinicopathological characteristics and survival outcomes in micropapillary urothelial carcinoma of the bladder: A SEER database analysis , 2020, Cancer medicine.
[22] C. Catalano,et al. VI-RADS Scoring Criteria for Alternative Risk-adapted Strategies in the Management of Bladder Cancer During the COVID-19 Pandemic , 2020, European Urology.
[23] S. Ou,et al. Neuregulin 1 Fusion-Positive NSCLC. , 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[24] A. Jemal,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.
[25] M. Wong,et al. The global epidemiology of bladder cancer: a joinpoint regression analysis of its incidence and mortality trends and projection , 2018, Scientific Reports.
[26] E. Pleasance,et al. Successful targeting of the NRG1 pathway indicates novel treatment strategy for metastatic cancer , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.
[27] C. Corless,et al. Durable Response to Afatinib in Lung Adenocarcinoma Harboring NRG1 Gene Fusions. , 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[28] D. Giannarelli,et al. The long-term prognostic value of survivin expressing circulating tumor cells in patients with high-risk non-muscle invasive bladder cancer (NMIBC) , 2017, Journal of Cancer Research and Clinical Oncology.
[29] J. Witjes,et al. MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER , 2016 .
[30] Fredrik Y Frejd,et al. Targeting HER3 using mono- and bispecific antibodies or alternative scaffolds , 2016, mAbs.
[31] W. Farhat,et al. Role of Sonic Hedgehog (Shh) Signaling in Bladder Cancer Stemness and Tumorigenesis , 2016, Current Urology Reports.
[32] Roman K. Thomas,et al. Molecular Pathways: Targeting NRG1 Fusions in Lung Cancer , 2014, Clinical Cancer Research.
[33] J. Witjes,et al. EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines. , 2014, European urology.
[34] R. Rodríguez-Barrueco,et al. Neuregulins and Cancer , 2008, Clinical Cancer Research.
[35] Douglas L Falls,et al. Neuregulins: functions, forms, and signaling strategies. , 2003, Experimental cell research.
[36] Robert C. Wolpert,et al. A Review of the , 1985 .
[37] J. Affeldt,et al. The feasibility study , 2019, The Information System Consultant’s Handbook.